Search

Your search keyword '"Dzeranova L K"' showing total 112 results
Start Over Author "Dzeranova L K" Search Limiters Full Text
112 results on '"Dzeranova L K"'

6. Clinical features, diagnostics and treatment of FGF23 secreting tumors: series of 40 clinical cases

Author

Gronskaia, S. A., primary, Belaya, Zh. E., additional, Rozhinskaya, L. Ya., additional, Melnichenko, G. A., additional, Dubovitskaya, T. A., additional, Mamedova, E. O., additional, Rodionova, S. S., additional, Buklemishev, Yu. V., additional, Pigarova, E. A., additional, Degtyarev, M. V., additional, Babaeva, D. M., additional, Vladimirova, V. P., additional, Tarbaeva, N. V., additional, Serzhenko, S. S., additional, Grigoriev, A. Yu., additional, Dzeranova, L. K., additional, Karpenko, V. Yu., additional, Karasev, A. L., additional, Fedotov, R. N., additional, Uliyanova, I. N., additional, Toroptsova, N. V., additional, Lesnyak, O. M., additional, Mokrysheva, N. G., additional, and Dedov, I. I., additional

Published
2023
Full Text
View/download PDF

7. Thyrotropin-secreting pituitary adenomas: clinical features and results of treatment in 45 patients

Author

Trukhina, D. A., primary, Przhiyalkovskaya, E. G., additional, Belaya, Zh. E., additional, Grigoriev, A. Yu., additional, Azizyan, V. N., additional, Mamedova, E. O., additional, Rozhinskaya, L. Ya., additional, Lapshina, A. M., additional, Pigarova, E. A., additional, Dzeranova, L. K., additional, Platonova, N. M., additional, Troshina, E. A., additional, and Melnichenko, G. A., additional

Published
2023
Full Text
View/download PDF

8. Clinical guidelines ‘Hyperprolactinemia’ (draft)

Author

Dedov, I. I., primary, Melnichenko, G. A., additional, Dzeranova, L. K., additional, Andreeva, E. N., additional, Grineva, E. N., additional, Marova, E. I., additional, Mokrysheva, N. G., additional, Pigarova, E. A., additional, Vorotnikova, S. Y., additional, Fedorova, N. S., additional, Shutova, A. S., additional, Przhiyalkovskaya, E. G., additional, Ilovaуskaya, I.  A., additional, Romantsova, T. I., additional, Dogadin, S. A., additional, and Suplotova, L. A., additional

Published
2023
Full Text
View/download PDF

11. Acromegaly in the differential diagnosis of hearing loss

Author

Dzeranova, L. K., primary, Lepeshkina, L. I., additional, Shutova, A. S., additional, Perepelova, M. A., additional, Pigarova, E. A., additional, Azizyan, V. N., additional, Akopyan, P. V., additional, Przhialkovskaya, Е. G., additional, Melnichenko, G. A., additional, and Mokrysheva, N. G., additional

Published
2023
Full Text
View/download PDF

17. Survival predictors in patients with ectopic acth syndrome

Author

Golounina, O. O., primary, Belaya, Zh. E., additional, Rozhinskaya, L. Ya., additional, Pikunov, M. Yu., additional, Markovich, A. A., additional, Dzeranova, L. K., additional, Marova, E. I., additional, Kuznetsov, N. S., additional, Fadeev, V. V., additional, Melnichenko, G. A., additional, and Dedov, I. I., additional

Published
2022
Full Text
View/download PDF

25. Vitamin D metabolite and calcium phosphorus metabolism in in patients with primary hyperparathyroidism on the background of bolus therapy with colecalciferol

Author

Maganeva, I. S., primary, Pigarova, E. A., additional, Shulpekova, N. V., additional, Dzeranova, L. K., additional, Eremkina, A. K., additional, Miliutina, A. P., additional, Povaliaeva, A. A., additional, Zhukov, A. Y., additional, Bogdanov, V. P., additional, Rozhinskaya, L. Ya., additional, and Mokrysheva, N. G., additional

Published
2021
Full Text
View/download PDF

27. Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis

Author

Belaya, Zh. E., primary, Belova, K. Yu., additional, Biryukova, E. V., additional, Dedov, I. I., additional, Dzeranova, L. K., additional, Drapkina, O. M., additional, Dreval, A. V., additional, Dubovitskaya, T. A., additional, Dudinskaya, E. N., additional, Ershova, O. B., additional, Zagorodniy, N. V., additional, Ilyukhina, O. B., additional, Kanis, J. A., additional, Kryukova, I. V., additional, Lesnyak, O. M., additional, Mamedova, E. O., additional, Marchenkova, L. A., additional, Mel’nichenko, G. A., additional, Nikankina, L. V., additional, Nikitinskaya, O. A., additional, Petryaikin, A. V., additional, Pigarova, E. A., additional, Rodionova, S. S., additional, Rozhinskaya, L. Ya., additional, Skripnikova, I. A., additional, Tarbaeva, N. V., additional, Tkacheva, O. N., additional, Toroptsova, N. V., additional, Farba, L. Ya., additional, Tsoriev, T. T., additional, Chernova, T. O., additional, Yureneva, S. V., additional, and Yakushevskaya, O. V., additional

Published
2021
Full Text
View/download PDF

33. Obesity associated with neuroleptic drugs, value of hyperprolactinemia

Author

Starostina E G, Yunilainen O A, and Dzeranova L K

Subjects
Neuroleptic Drugs, medicine.medical_specialty, Nutrition and Dietetics, Physiology, business.industry, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, QD415-436, medicine.disease, Biochemistry, Obesity, Endocrinology, Internal medicine, Internal Medicine, medicine, QP1-981, business, Value (mathematics)
Published
2013

34. Sleep-disordered breathing in acromegaly

Author

Averkieva E, Bezunov E A, Rozhinskaya L Ya, Vorontsov A, Dzeranova L K, Vladimirova V P, Artemova E, and Kuznetsov D I

Subjects
Pediatrics, medicine.medical_specialty, Physiology, Endocrinology, Diabetes and Metabolism, pituitary adenoma, QD415-436, Disease, Biochemistry, Endocrinology, Quality of life, Acromegaly, Internal Medicine, medicine, QP1-981, Radiation treatment planning, Nutrition and Dietetics, business.industry, Public Health, Environmental and Occupational Health, Sleep apnea, sleep apnea, medicine.disease, Concomitant, Anesthesia, Breathing, Sleep disordered breathing, business
Abstract

Sleep-disordered breathing is higly prevalent in acromegaly, disturbing patients quality of life and increasing the risk of acute cardiovascular compications. Presented clinical case discusses key considerations for timely diagnosis of sleep apnea syndrome and treatment planning. The case of 41 y.o. woman with newly diagnosed acromegaly and concomitant sleep apnea is typical for this disease.

Published
2013

35. Metabolic complications of endogenous Cushing: patient selection for screening

Author

Dzeranova L K, Dragunova N, Marova E I, Rozhinskaya L Y, Molitvoslovova N N, Dedov I I, Mel'nichenko G A, Belaya Zh E, Arapova S D, and Zenkova T S

Subjects
endocrine system, medicine.medical_specialty, Physiology, Endocrinology, Diabetes and Metabolism, Population, QD415-436, cortisol, Biochemistry, Gastroenterology, Endocrinology, Diabetes mellitus, Internal medicine, Internal Medicine, medicine, QP1-981, Adrenal adenoma, complications of hypercortisolism, education, acth, education.field_of_study, Nutrition and Dietetics, business.industry, cushing's disease, Public Health, Environmental and Occupational Health, Muscle weakness, Cushing's disease, medicine.disease, endogenous hypercortisolism, Amenorrhea, medicine.symptom, Metabolic syndrome, business, Weight gain, hormones, hormone substitutes, and hormone antagonists
Abstract

Aims: this study evaluates the most common associations of symptoms and complications in patients with Cushing’s syndrome (CS) in order to choose a potential population to be screened for CS and estimates the diagnostic accuracy of first line screening tests (cortisol, ACTH) to differentiate ACTH-ectopic CS from Cushing’s disease. Materials and Methods: The clinical data of 259 patients with proven CS during 2001–2011 was analyzed. The clinical presentations of 197 patients (159 Cushing’s disease, 28 ACTH-ectopic CS and 10 cases of benign cortisol-secreting adrenal adenoma) were compared according to the cause of hypercortisolism. ROC-analysis was performed to estimate the diagnostic accuracy of the first line tests (cortisol, ACTH) to suggest ACTH-ectopic CS. A threshold for the test with the highest area under the curves was chosen based on the maximum sum of the sensitivity and specificity. Results: The most frequent complaints were related to fatigue, muscle weakness, weight gain and changes in appearance (facial plethora and fullness, striae). Among the complications of CS the most frequent were being overweight or obese (71%), hypertension (63%), dislipoproteinemia (41%), low traumatic fractures (43%) and steroid-induced diabetes (31%). In women, 16% were older than 50, in those who were younger amenorrhea was registered in 43%. The patients with ACTH-ectopic CS had higher rate of low traumatic fractures (p=0.04), increased serum late-night cortisol, 24 hours urinary free cortisol, morning and evening ACTH and lower levels of potassium (p0.01 for all parameters). Plasma late-night ACTH measurements showed the highest AUC (0,811 (95% CI 0,712–0,909)) to differentiate ACTH-ectopic CS from Cushing’s disease. A cut off value of 108.9 pg/ml for late-night ACTH yielded a sensitivity of 60,7% and a specificity of 79%. Conclusions: patients with a coexistence of obesity, muscle weakness, fatigue, some components of metabolic syndrome and especially low traumatic fractures should be screened for CS. High plasma late night ACTH values in patients with proven CS value suggest ACTH-ectopic syndrome.

Published
2013

36. New opportunities in the treatment and management of acromegaly

Author

Rozhinskaya L Ya, Pigarova E A, Dzeranova L K, Dedov I I, and Dalantaeva N S

Subjects
Genetics, Nutrition and Dietetics, Physiology, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, QD415-436, Biology, medicine.disease, Biochemistry, Endocrinology, ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN, Acromegaly, Internal Medicine, medicine, QP1-981, aip, pituitary adenomas, fipa, Gene
Abstract

Genetic aspects of familial isolated pituitary adenomas (FIPA) are expanding rapidly in the last few years. Around 20% of these FIPA families have been identified to have mutations within the aryl hydrocarbon receptor interacting protein (AIP) gene. The number of identified AIP-positive FIPA families is increasing all over the world.

Published
2012

37. Giperkortitsizm i metabolicheskiy sindrom: slozhnosti differentsial'noy diagnostiki i lecheniya

Author

Rozhinskaya L Ya, Dzeranova L K, Kolesnikova G S, Grigor'ev A Yu, Belaya Zh E, Pankratova Yu, Manchenko O, and Pigarova E A

Subjects
obesity, medicine.medical_specialty, Pediatrics, Physiology, Endocrinology, Diabetes and Metabolism, Cushingoid, QD415-436, Disease, Biochemistry, metabolic syndrome, Endocrinology, Internal medicine, Internal Medicine, QP1-981, Medicine, Endocrine system, Pathological, Nutrition and Dietetics, hypercortisolism, business.industry, Public Health, Environmental and Occupational Health, medicine.disease, Obesity, Cushing Disease, cushing disease, Differential diagnosis, Metabolic syndrome, business
Abstract

Hypercortisolism is a severe endocrine disorder that leads to all types of metabolic disturbances. The most frequent symptom of hypercortisolism is a specific weight gain and body fat distribution - "cushingoid" obesity which clinically reflects the pathological changes in protein, carbohydrate and lipids metabolism. We provide a clinical case of a patient with Cushings disease. This clinical case represents challenges in the differential diagnosis of this rare endocrine disorder and metabolic syndrome, and specific approach in further evaluation and treatment of Cushing's disease that requires all the latest technology in this field to be employed.

Published
2012

38. Metabolicheskie effekty gormona rosta

Author

Dzeranova L K, Pigarova E A, and Vorotnikova S Yu

Subjects
Nutrition and Dietetics, Endocrinology, Physiology, business.industry, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Internal Medicine, QP1-981, Medicine, QD415-436, business, Biochemistry
Published
2011

39. Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2

Author

Gerasimenko O A, Dzeranova L K, and Pigarova E A

Subjects
Agonist, medicine.medical_specialty, diabetes mellitus type 2, insulin, medicine.drug_class, Physiology, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, QD415-436, Biochemistry, Endocrinology, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, QP1-981, bromocriptine, Nutrition and Dietetics, business.industry, Insulin, Dopaminergic, Public Health, Environmental and Occupational Health, Type 2 Diabetes Mellitus, medicine.disease, Bromocriptine, Postprandial, Dopamine receptor, dopamine, business, medicine.drug
Abstract

Bromocriptine is a sympatholytic agonist of dopamine receptors, which is now proposed for treatment of type 2 diabetes mellitus. In animal studies bromocriptine elevates the decreased levels of dopamine in hypothalamus and blocks excessive sympathetic innervations in central nervous system that results in decrease of postprandial glucose. Bromocriptine decreases hepatic glucose production and increases insulin secretion and muscle insulin sensitivity. This article reviews experimental and clinical data on the use of bromocriptine for treatment of type 2 diabetes mellitus

Published
2011

40. Autozhel' v kontrole biokhimicheskikh markerovaktivnosti akromegalii: predstavlenieklinicheskogo sluchaya

Author

Dzeranova L K, Pigarova E A, Dalantaeva N S, Rozhinskaya L Ya, and Giniyatullina E N

Subjects
medicine.medical_specialty, Pediatrics, Pituitary gland, Physiology, Endocrinology, Diabetes and Metabolism, Disease, QD415-436, Lanreotide, Biochemistry, chemistry.chemical_compound, Endocrinology, somatulin autogel, Quality of life, Acromegaly, Internal Medicine, medicine, QP1-981, Patient treatment, Surgical treatment, Excess growth hormone, Nutrition and Dietetics, business.industry, Public Health, Environmental and Occupational Health, medicine.disease, Surgery, medicine.anatomical_structure, chemistry, acromegaly, lanreotide, business, somatostatin analog
Abstract

Acromegaly is a severe neuroendocrine disease that develops when the pituitary gland produces excess growth hormone (GH). Acromegaly is not only a cosmetic problem. Hypersecretion of GH leads to variety complications, decreased quality of life, shortening the expected lifespan due to development of severe cardiovascular complications. Timely diagnosis and adequate treatment can reduce mortality by 2-5 times and medical therapy deservedly plays an important role in treatment of patients with acromegaly when radical surgical treatment cannot be performed. We present a first Russian experience of acromegaly patient treatment with new preparation - Somatulin Autogel, with analysis of its favorable effects on clinical and metabolic manifestations of the disease.

Published
2010

41. Sindrom khronicheskoy ustalosti: sovremennye predstavleniya ob etiologii

Author

Pigarova E A, Dzeranova L K, Rozhinskaya L Ya, and Pleshcheva A

Subjects
medicine.medical_specialty, Weakness, Physiology, etiology, Endocrinology, Diabetes and Metabolism, media_common.quotation_subject, virus, QD415-436, Disease, chronic fatigue syndrome, Biochemistry, Endocrinology, weakness, Internal Medicine, Chronic fatigue syndrome, QP1-981, Medicine, Psychiatry, Depression (differential diagnoses), media_common, Mental work, Nutrition and Dietetics, business.industry, Public Health, Environmental and Occupational Health, medicine.disease, immunity, Feeling, Etiology, medicine.symptom, business
Abstract

Chronic fatigue syndrome is a disease of unexplained feeling of profound fatigue lasting for more than 6 months. This fatigue is not relieved even after prolonged rest and is exacerbated after physical or mental work. More than 3000 scientific studies had proved that chronic fatigue syndrome is not a form of depression or hypochondria. It is a real somatic illness that results in professional, social and individual desadaptation. This article summarizes the contemporary etiological conceptions of this condition.

Published
2010

42. Klinicheskiy sluchay gigantskoy prolaktin-sekretiruyushchey adenomy gipofiza u podrostka

Author

Vorontsov A, Pigarova E A, Dzeranova L K, Giniyatullina E N, Rozhinskaya L Ya, and Grigor'ev A Yu

Subjects
medicine.medical_specialty, prolactin, Nutrition and Dietetics, Adult patients, prl, Physiology, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, QD415-436, Dermatology, Biochemistry, Endocrinology, children, Internal medicine, prolactinoma, Internal Medicine, medicine, dopamine agonists, Treatment strategy, cabergoline, QP1-981, Clinical case, Psychology, Surgical treatment
Abstract

Резюме. Пролактиномы редко выявляются у лиц детского возраста, но зачастую характеризуются более агрессивным ростом. И, несмотря на то, что подходы к лечению этих опухолей у взрослых хорошо изучены и в настоящее время предпочтение отдается медикаментозной терапии агонистами дофамина, применение этих препаратов у детей ограничено из-за отсутствия данных о безопасности и эффективности их применения на этой группе пациентов. Каберголин в качестве медикаментозной терапии является препаратом выбора в лечении пролактином у взрослых пациентов. Представленный нами клинический случай демонстрирует высокую эффективность и хорошую переносимость каберголина у мальчика 14 лет с гигантской пролактиномой, осложненной зрительными, неврологическими и метаболическими нарушениями, что позволило на данном этапе воздержаться от оперативного лечения, а также нивелировать или уменьшить проявления осложнений заболевания. Resume. Prolactinomas are very rare, but usually more aggressive among children, than in adults. Although treatment strategies for prolactinomas in adults are well established and at present time the preference is given to dopamine agonists, the use of these drugs in pediatric patients is limited due to lack of information on safety and efficiency in this group of patients. Cabergoline is a drug of choice for treatment adult patients with prolactinomas. This clinical case that we report here demonstrates high efficiency and tolerability of cabergoline in a 14-year patient with giant prolactinoma, complicated by visual, neurological and metabolic disturbances, which allowed us to refrain from surgical treatment and to reduce the degree of complications.

Published
2010

43. ACTH-ectopic syndrome in patient with lung carcinoid

Author

Mikhailova D S, Manchenko O, Pigarova E A, Kim I, Bel'tsevich D G, Dzeranova L K, Urazovsky N Yu, Rozhinskaya LYa, Kuznetsov N S, Vorontsov A, and Pekareva E

Subjects
carcinoid, medicine.medical_specialty, Pathology, endocrine system, Physiology, Endocrinology, Diabetes and Metabolism, QD415-436, Gastroenterology, Biochemistry, Endocrinology, Internal medicine, Internal Medicine, medicine, acth-ectopic syndrome, QP1-981, In patient, Surgical treatment, Radical treatment, Nutrition and Dietetics, Lung, hypercortisolism, business.industry, Public Health, Environmental and Occupational Health, medicine.anatomical_structure, Endocrine pathology, Clinical case, business, neuroendocrine tumor
Abstract

ACTH-ectopic hypercortisolism is one of the most соmplex variants of endocrine pathology presenting with v arious metabolic changes. Its early localization still represents a cornerstone of radical treatment of such patients. In this article w e discuss a clinical case of woman with ectopic secretion of ACTH by malignant lung carcinoid, which localization and therefore surgical treatment wаs possible only after three-year period of extensive diagnostic workup.

Published
2009

45. Idiopathic edema: state of the art

Author

Dzeranova L K and Pigarova E A

Subjects
Idiopathic edema, medicine.medical_specialty, Nutrition and Dietetics, Physiology, business.industry, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Excess weight, QD415-436, Biochemistry, Surgery, Endocrinology, Orthostatic edema, Internal medicine, Internal Medicine, Cardiology, QP1-981, Medicine, business
Abstract

In this article we will try to highlight recent advances in the study of this mysterious problem as idiopathic edema (IE), exposing the most common myths of the disease. Idiopathic edema - a syndrome that is excess weight gain, which has no known cause. Other terms to describe this state is: "cyclic and periodic swelling," "syndrome fluid retention" and "orthostatic edema."

Published
2008

46. SUMMARY OF CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS OF THE RUSSIAN ASSOCIATION OF ENDOCRINOLOGISTS

Author

Melnichenko, G A, primary, Belaya, Zh E, additional, Rozhinskaya, L Ya, additional, Grebennikova, T A, additional, Pigarova, E A, additional, Toroptsova, N V, additional, Nikitinskaya, O A, additional, Farba, L Ya, additional, Tarbaeva, N V, additional, Chernova, T O, additional, Dzeranova, L K, additional, Ilyin, A V, additional, Yureneva, S V, additional, Kryukova, I V, additional, Mamedova, E O, additional, Biryukova, E V, additional, Zagorodny, N V, additional, Rodionova, S S, additional, Lesniak, O M, additional, Skripnikova, I A, additional, Dreval, A V, additional, Alekseeva, L A, additional, and Dedov, I I, additional

Published
2016
Full Text
View/download PDF

47. Novye gorizonty primeneniya tiazolidindionov

Author

Dzeranova L K and Pigarova E A

Subjects
Nutrition and Dietetics, Endocrinology, Physiology, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Internal Medicine, QP1-981, QD415-436, Biochemistry
Published
2006

48. Ozhirenie i ginekomastiya u patsienta s tsentral'nym nesakharnym diabetom

Author

Grigor'ev A Yu, Dzeranova L K, Rozhinskaya L Ya, Tishova Yu A, Azizyan V N, Vorontsov A, and Pigarova E A

Subjects
Nutrition and Dietetics, Endocrinology, business.industry, Physiology, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Internal Medicine, Medicine, QP1-981, QD415-436, business, Biochemistry
Published
2006

50. Individualizatsiya terapii tsentral'nogo nesakharnogo diabeta: klinicheskiy sluchay primeneniya preparata «Presayneks»

Author

Dzeranova L K, Pigarova E A, and Rozhinskaya L Ya

Subjects
medicine.medical_specialty, Vasopressin, desmopressin, Arginine, genetic structures, vasopressin, Physiology, Endocrinology, Diabetes and Metabolism, hystiocytosis, QD415-436, presinex, Biochemistry, Thirst, Excretion, Endocrinology, Internal medicine, Internal Medicine, medicine, QP1-981, Desmopressin, Nutrition and Dietetics, business.industry, Public Health, Environmental and Occupational Health, medicine.disease, minirin, Vasopressin secretion, diabetes insipidus, Diabetes insipidus, Nasal administration, medicine.symptom, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug
Abstract

Central diabetes insipidus (CDI) - a severe disease with disturbance of arginine vasopressin secretion, with excretion of large amounts of hypotonic urine, which leads to dehydration and thirst. Desmopressin, a synthetic analog of arginine vasopressin, is used to compensate a water-electrolyte balance in patients with CDI is available in forms of intranasal spray and tablets. Herein we present a clinical case of a patient with longstanding CDI due to Langerhans cell hystiocytosis in childhood who received different medications for treatment of CDI symptoms that demonstrates variable efficiency and tolerance of these drugs.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results